NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) has announced financial results for the first quarter of 2024, with reported sales growth of 2.3 percent to $21.4 billion, operational growth of 3.9 percent, and adjusted operational growth of 4.0 percent. Sales in the U.S. increased 7.8 percent for the first quarter. “Johnson & Johnson’s solid first quarter performance reflects our sharpened focus and the progress in our portfolio and pipeline,” said Joaquin Duato, chairman and chief executive officer. “Our impact across the full spectrum of health care is unique in our industry, and the milestones achieved this quarter reinforce our position as an innovation powerhouse.” Read More